PDL BioPharma, Inc. Financing cash flow

Financing cash flow of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Financing cash flow growth rates and interactive chart.


Highlights and Quick Summary

  • Financing cash flow for the quarter ending June 29, 2020 was $-20 Million (a -50.79% decrease compared to previous quarter)
  • Year-over-year quarterly Financing cash flow increased by 27.11%
  • Annual Financing cash flow for 2019 was $-191 Million (a 8.27% increase from previous year)
  • Annual Financing cash flow for 2018 was $-176 Million (a 47.37% increase from previous year)
  • Annual Financing cash flow for 2017 was $-119 Million (a 312.62% increase from previous year)
  • Twelve month Financing cash flow ending June 29, 2020 was $-179 Million (a -3.73% decrease compared to previous quarter)
  • Twelve month trailing Financing cash flow increased by 58.9% year-over-year
Trailing Financing cash flow for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
$-179 Million $-186 Million $-191 Million $-113 Million
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Financing cash flow of PDL BioPharma, Inc.

Most recent Financing cash flowof PDLI including historical data for past 10 years.

Interactive Chart of Financing cash flow of PDL BioPharma, Inc.

PDL BioPharma, Inc. Financing cash flow for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $-20.05 $-40.73
2019 $-102.4 $-15.77 $-26.98 $-45.36 $-190.51
2018 $-24.51 $-1.4 $-20.04 $-130.01 $-175.96
2017 $-0.2 $-87.01 $-24.52 $-7.67 $-119.4
2016 $12.57 $-0.08 $-8.2 $-33.23 $-28.94
2015 $-92.69 $-49.54 $-204.58 $52.51 $-294.31
2014 $-70.0 $-42.26 $-42.8 $197.95 $42.9
2013 $53.13 $-20.99 $-20.97 $-20.98 $-9.82
2012 $-21.03 $-43.71 $-67.75 $-45.65 $-178.13
2011 $-42.24 $-47.32 $-57.94 $-41.28 $-188.76
2010 $-8.81 $-27.1 $-192.65 $-239.06

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.